JRCT ID: jRCTs031210002
Registered date:01/04/2021
Phase II study of concurrent intensity modulated radiation therapy with docetaxel, cisplatin and 5-FU for advanced squamous cell carcinoma of cervical esophagus in Japan
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Esophageal cancer |
| Date of first enrollment | 07/01/2022 |
| Target sample size | 43 |
| Countries of recruitment | |
| Study type | Interventional |
| Intervention(s) | protocol |
Outcome(s)
| Primary Outcome | 3 year over-all survival |
|---|---|
| Secondary Outcome | protocol |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | protocol |
| Exclude criteria | protocol |
Related Information
| Primary Sponsor | Watanabe Akinori |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Akinori Watanabe |
| Address | 1-15-1, Kitazato, Minami-ku, Sagamihara-shi Kanagawa Kanagawa Japan 252-0374 |
| Telephone | +81-42-778-8111 |
| akinori@kitasato-u.ac.jp | |
| Affiliation | Kitasato university Hospital |
| Scientific contact | |
| Name | Akinori Watanabe |
| Address | 1-15-1, Kitazato, Minami-ku, Sagamihara-shi Kanagawa Kanagawa Japan 252-0374 |
| Telephone | +81-42-778-8111 |
| akinori@kitasato-u.ac.jp | |
| Affiliation | Kitasato university Hospital |